Share This

Hot News

【新冠疫苗】Moderna起訴輝瑞及BioNTech 稱其新冠疫苗mRNA技術侵權- 香港經濟日報- 即時新聞頻道- iMoney智富 ... @ 2022-08-29T00: Back Hot News
Keyword:莫德納 專利 告輝瑞 新冠疫苗
Concept:莫德納告輝瑞 , 新冠疫苗技術專利
莫德納新聞稿表示:「莫德納認為,輝瑞和BNT開發的新冠疫苗COMIRNATY,侵害莫德納在2010至2016年間所提交涵蓋基礎MRNA科技專利。這項具突破性的科技對於莫德納開發自己的新冠疫苗SPIKEVAX至關重要。而輝瑞和BNT在未經莫德納允許的情況下,復制了這項科技開發自己的新冠疫苗。」
美國制藥廠莫德納(MODERNA)26日正式向輝瑞藥廠及德國BIONTECH提出告訴,指控兩者合作研發的新冠疫苗專利侵權,復制了莫德納公司在新冠疫情爆發前幾年所開發的MRNA技術。
據《紐約時報》、路透社當地時間8月26日報道,莫德納當天起訴輝瑞和BNT合作開發的新冠疫苗專利侵權,抄襲了莫德納在疫情發生前幾年所開發的技術,據莫德納形容這是一種「開創性的技術」(GROUNDBREAKING TECHNOLOGY)。
莫德納宣布提告輝瑞、BNT 盜用MRNA專利開發新冠疫苗

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.